Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to 27 months, keeping alive one of the last remaining hopes for this ...

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. In partnership with industry collaborators ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

Casdatifan data were better on every efficacy measure evaluated, across all four monotherapy cohorts (n=121) of the Phase 1/1b ARC-20 study in late-line metastatic kidney cancer, relative to published ...

In the 100mg tablet cohort, Phase 3 dose and formulation, casdatifan showed a 35% confirmed overall response rate (ORR), with two additional responses pending confirmation, and median progression-free ...

Get local news delivered to your inbox!

Fort Worth Police seized guns, drugs, and money in an operation that took place across five locations. Fort Worth Police Department The Fort Worth police said Monday that officers had recently seized ...

Kimani Vidal reacts in the second half against the Washington Commanders at SoFi Stadium. Gary A. Vasquez / Imagn Images I’m old enough to remember when running backs weren’t getting hurt at every ...

We're off and running with the sixth week of waiver wire pickups in fantasy football as Week 7 looms. But you might be thinking about which players on your roster to keep or to drop as you make those ...

The government has seized $15 billion in bitcoin from an alleged cryptocurrency fraud kingpin accused of running forced labor camps in Cambodia, where prisoners were forced to run “pig-butchering” ...

The U.S. Department of Agriculture has posted a notice on its website saying federal food aid will not go out Nov. 1 as the government shutdow… Buckingham Palace says that King Charles III is ...